SYN Financial Statements From 2010 to 2024

1777 Stock  TWD 97.20  0.20  0.21%   
SYN Tech financial statements provide useful quarterly and yearly information to potential SYN Tech Chem Pharm investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on SYN Tech financial statements helps investors assess SYN Tech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting SYN Tech's valuation are summarized below:
SYN Tech Chem Pharm does not currently have any fundamental trend indicators for analysis.
Check SYN Tech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SYN Tech's main balance sheet or income statement drivers, such as , as well as many indicators such as . SYN financial statements analysis is a perfect complement when working with SYN Tech Valuation or Volatility modules.
  
This module can also supplement various SYN Tech Technical models . Check out the analysis of SYN Tech Correlation against competitors.

SYN Tech Chem Pharm Company Current Valuation Analysis

SYN Tech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current SYN Tech Current Valuation

    
  3.16 B  
Most of SYN Tech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SYN Tech Chem Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, SYN Tech Chem Pharm has a Current Valuation of 3.16 B. This is 77.97% lower than that of the Healthcare sector and 31.9% lower than that of the Biotechnology industry. The current valuation for all Taiwan stocks is 80.97% higher than that of the company.

SYN Tech Chem Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining SYN Tech's current stock value. Our valuation model uses many indicators to compare SYN Tech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SYN Tech competition to find correlations between indicators driving SYN Tech's intrinsic value. More Info.
SYN Tech Chem Pharm is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.27  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for SYN Tech Chem Pharm is roughly  3.69 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SYN Tech's earnings, one of the primary drivers of an investment's value.

About SYN Tech Financial Statements

SYN Tech investors use historical fundamental indicators, such as SYN Tech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in SYN Tech. Please read more on our technical analysis and fundamental analysis pages.
Co., Ltd. researches, manufactures, and sells APIs in Taiwan. The company was founded in 1982 and is based in Tainan City, Taiwan. SYN TECH operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 175 people.

Pair Trading with SYN Tech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SYN Tech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SYN Tech will appreciate offsetting losses from the drop in the long position's value.

Moving against SYN Stock

  0.522888 Shin Kong Financial Earnings Call This WeekPairCorr
  0.476547 Medigen Vaccine BiologicsPairCorr
  0.464743 Oneness BiotechPairCorr
  0.44174 OBI PharmaPairCorr
  0.354142 Adimmune CorpPairCorr
The ability to find closely correlated positions to SYN Tech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SYN Tech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SYN Tech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SYN Tech Chem Pharm to buy it.
The correlation of SYN Tech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SYN Tech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SYN Tech Chem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SYN Tech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for SYN Stock Analysis

When running SYN Tech's price analysis, check to measure SYN Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SYN Tech is operating at the current time. Most of SYN Tech's value examination focuses on studying past and present price action to predict the probability of SYN Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SYN Tech's price. Additionally, you may evaluate how the addition of SYN Tech to your portfolios can decrease your overall portfolio volatility.